Literature DB >> 23335655

Target organ damage and cardiovascular risk factors among subjects with previously undiagnosed hypertension.

Päivi E Korhonen1, Hannu Kautiainen2, Salme Järvenpää3, Ilkka Kantola4.   

Abstract

BACKGROUND: Little is known about the prevalence of target organ damage in previously undiagnosed hypertension.
DESIGN: Cross-sectional population survey.
METHODS: We measured ankle-brachial index (ABI), estimated glomerular filtration rate (eGFR), electrocardiographically determined left ventricular hypertrophy (ECG-LVH), and cardiometabolic risk factors in subjects with previously undiagnosed hypertension (n = 138) and normotensive (n = 440) risk subjects, who had metabolic syndrome, glucose disorders, body mass index ≥ 30 kg/m(2) or a 10-year risk of cardiovascular disease death of 5% or more according to the Systematic Coronary Risk Evaluation (SCORE) system. None of the subjects had established cardiovascular or renal disease or previously diagnosed diabetes.
RESULTS: There was no difference (p = 0.68) among the studied age-groups in the prevalence of previously undiagnosed hypertension, and no interaction (p = 0.10) was found between sex and age groups. Evidence of subclinical organ damage defined as ECG-LVH, ABI ≤ 0.90, or eGFR < 60 ml/min/1.73 m(2) were found in 22% of the subjects with previously undiagnosed hypertension, and 8% of the non-hypertensive risk persons (p < 0.001). The prevalence of renal insufficiency did not differ between the study groups. Majority of the subjects with previously undiagnosed hypertension also have multiple cardiometabolic risk factors.
CONCLUSIONS: Among subjects with previously undiagnosed hypertension, one in five patients had evidence of subclinical target organ damage, and three in four patients may be regarded as having high cardiovascular risk. © The European Society of Cardiology 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Hypertension; left ventricular hypertrophy; peripheral arterial disease; renal insufficiency; risk factors

Mesh:

Year:  2013        PMID: 23335655     DOI: 10.1177/2047487312474530

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  8 in total

1.  Target organ damage and control of cardiovascular risk factors in hypertensive patients. Evidence from the multicenter ESTher registry.

Authors:  R K Reibis; M Huber; M Karoff; W Kamke; R Kreutz; K Wegscheider; H Völler
Journal:  Herz       Date:  2015-01-30       Impact factor: 1.443

2.  Current obstacles in management of hypertensive patients by performance-based care and importance of diagnostic tests.

Authors:  Fatih Yalçin; Theodore P Abraham; Mario J Garcia
Journal:  Int J Cardiol Heart Vasc       Date:  2015-10-20

3.  Hypertension should be ruled out in patients with hyperdynamic left ventricle on radionuclide myocardial perfusion imaging, diastolic dysfunction and dyspnea on exertion.

Authors:  Fatih Yalçin; Thomas Schindler; Theodore P Abraham
Journal:  Int J Cardiol Heart Vasc       Date:  2015-04-09

4.  Examining elevated blood pressure and the effects of diabetes self-management education on blood pressure among a sample of Marshallese with type 2 diabetes in Arkansas.

Authors:  Pearl A McElfish; Christopher R Long; Zoran Bursac; Aaron J Scott; Harish E Chatrathi; Ka'imi A Sinclair; Nirav Nagarsheth; Mikaila Calcagni; Jay Patolia; Marie-Rachelle Narcisse
Journal:  PLoS One       Date:  2021-04-22       Impact factor: 3.240

Review 5.  Hemodynamic stress and microscopic remodeling.

Authors:  Fatih Yalçin; Hulya Yalçin; Roselle Abraham; Theodore P Abraham
Journal:  Int J Cardiol Cardiovasc Risk Prev       Date:  2021-11-02

6.  Prognostic value of left ventricular hypertrophy in postoperative outcomes in type A acute aortic dissection.

Authors:  Yifan Zuo; Yun Xing; Zhiwei Wang; Zhiyong Wu; Zhipeng Hu; Rui Hu; Feng Shi; Tianyu Liu; Liang Liu
Journal:  J Thorac Dis       Date:  2022-08       Impact factor: 3.005

7.  Relationships between blood pressure measurements and target organ damage: Data from the Korea women's chest pain registry.

Authors:  Min Gyu Kong; Hack-Lyoung Kim; Myung-A Kim; Mina Kim; Seong Mi Park; Hyun Ju Yoon; Mi Seung Shin; Kyung-Soon Hong; Gil Ja Shin; Wan-Joo Shim
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-10-25       Impact factor: 3.738

8.  Undiagnosed hypertension in Peru: analysis of associated factors and socioeconomic inequalities, 2019.

Authors:  Delia Vanessa Guerrero-Díaz; Akram Hernández-Vásquez; Wency Cecilia Montoya-Rivera; Carlos Rojas-Roque; Manuel Alberto Chacón Díaz; Guido Bendezu-Quispe
Journal:  Heliyon       Date:  2021-07-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.